Ad is loading...
GILD
Price
$89.76
Change
+$1.13 (+1.27%)
Updated
Nov 21 closing price
81 days until earnings call
RHHBY
Price
$35.29
Change
+$0.16 (+0.46%)
Updated
Nov 21 closing price
69 days until earnings call
Ad is loading...

GILD vs RHHBY

Header iconGILD vs RHHBY Comparison
Open Charts GILD vs RHHBYBanner chart's image
Gilead Sciences
Price$89.76
Change+$1.13 (+1.27%)
Volume$4.06M
CapitalizationN/A
Roche Holding
Price$35.29
Change+$0.16 (+0.46%)
Volume$1.46M
CapitalizationN/A
GILD vs RHHBY Comparison Chart
Loading...
GILD
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
RHHBY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
GILD vs. RHHBY commentary
Nov 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GILD is a StrongBuy and RHHBY is a Sell.

COMPARISON
Comparison
Nov 22, 2024
Stock price -- (GILD: $89.76 vs. RHHBY: $35.29)
Brand notoriety: GILD: Notable vs. RHHBY: Not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: GILD: 57% vs. RHHBY: 128%
Market capitalization -- GILD: $90.79B vs. RHHBY: $250.69B
GILD [@Pharmaceuticals: Major] is valued at $90.79B. RHHBY’s [@Pharmaceuticals: Major] market capitalization is $250.69B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GILD’s FA Score shows that 3 FA rating(s) are green whileRHHBY’s FA Score has 1 green FA rating(s).

  • GILD’s FA Score: 3 green, 2 red.
  • RHHBY’s FA Score: 1 green, 4 red.
According to our system of comparison, GILD is a better buy in the long-term than RHHBY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GILD’s TA Score shows that 3 TA indicator(s) are bullish while RHHBY’s TA Score has 5 bullish TA indicator(s).

  • GILD’s TA Score: 3 bullish, 5 bearish.
  • RHHBY’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, RHHBY is a better buy in the short-term than GILD.

Price Growth

GILD (@Pharmaceuticals: Major) experienced а -2.55% price change this week, while RHHBY (@Pharmaceuticals: Major) price change was -2.35% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -2.99%. For the same industry, the average monthly price growth was -8.46%, and the average quarterly price growth was +0.45%.

Reported Earning Dates

GILD is expected to report earnings on Feb 11, 2025.

RHHBY is expected to report earnings on Jan 30, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (-2.99% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RHHBY($251B) has a higher market cap than GILD($90.8B). RHHBY has higher P/E ratio than GILD: RHHBY (19.46) vs GILD (16.20). GILD YTD gains are higher at: 14.368 vs. RHHBY (1.404). RHHBY has higher annual earnings (EBITDA): 19.1B vs. GILD (10.5B). RHHBY (7.51B) and GILD (7.26B) have equal amount of cash in the bank . GILD (25B) and RHHBY (25.4B) have identical debt. RHHBY has higher revenues than GILD: RHHBY (60B) vs GILD (27.1B).
GILDRHHBYGILD / RHHBY
Capitalization90.8B251B36%
EBITDA10.5B19.1B55%
Gain YTD14.3681.4041,023%
P/E Ratio16.2019.4683%
Revenue27.1B60B45%
Total Cash7.26B7.51B97%
Total Debt25B25.4B98%
FUNDAMENTALS RATINGS
GILD vs RHHBY: Fundamental Ratings
GILD
RHHBY
OUTLOOK RATING
1..100
7565
VALUATION
overvalued / fair valued / undervalued
1..100
83
Overvalued
10
Undervalued
PROFIT vs RISK RATING
1..100
1879
SMR RATING
1..100
8899
PRICE GROWTH RATING
1..100
2160
P/E GROWTH RATING
1..100
148
SEASONALITY SCORE
1..100
n/a40

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RHHBY's Valuation (10) in the null industry is significantly better than the same rating for GILD (83) in the Biotechnology industry. This means that RHHBY’s stock grew significantly faster than GILD’s over the last 12 months.

GILD's Profit vs Risk Rating (18) in the Biotechnology industry is somewhat better than the same rating for RHHBY (79) in the null industry. This means that GILD’s stock grew somewhat faster than RHHBY’s over the last 12 months.

GILD's SMR Rating (88) in the Biotechnology industry is in the same range as RHHBY (99) in the null industry. This means that GILD’s stock grew similarly to RHHBY’s over the last 12 months.

GILD's Price Growth Rating (21) in the Biotechnology industry is somewhat better than the same rating for RHHBY (60) in the null industry. This means that GILD’s stock grew somewhat faster than RHHBY’s over the last 12 months.

GILD's P/E Growth Rating (1) in the Biotechnology industry is somewhat better than the same rating for RHHBY (48) in the null industry. This means that GILD’s stock grew somewhat faster than RHHBY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GILDRHHBY
RSI
ODDS (%)
Bearish Trend 1 day ago
42%
Bullish Trend 1 day ago
53%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
55%
Bullish Trend 1 day ago
58%
Momentum
ODDS (%)
Bearish Trend 1 day ago
52%
Bearish Trend 1 day ago
61%
MACD
ODDS (%)
Bearish Trend 1 day ago
37%
Bearish Trend 1 day ago
67%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
49%
Bearish Trend 1 day ago
45%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
61%
Bearish Trend 1 day ago
50%
Advances
ODDS (%)
Bullish Trend 1 day ago
58%
Bullish Trend 18 days ago
52%
Declines
ODDS (%)
Bearish Trend 7 days ago
50%
Bearish Trend 2 days ago
44%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
52%
Bullish Trend 1 day ago
55%
Aroon
ODDS (%)
Bullish Trend 1 day ago
56%
Bullish Trend 1 day ago
33%
View a ticker or compare two or three
Ad is loading...
GILD
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
RHHBY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JACLX18.560.29
+1.59%
JHancock Mid Cap Growth C
RYVVX88.731.11
+1.27%
Rydex S&P 500 Pure Value C
NWAWX17.810.09
+0.51%
Nationwide GQG US Quality Eq Instl Ser
RGPAX21.26N/A
N/A
RBC Global Opportunities A
CGWRX71.82-0.01
-0.01%
Columbia Large Cap Growth R

RHHBY and

Correlation & Price change

A.I.dvisor indicates that over the last year, RHHBY has been loosely correlated with RHHVF. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if RHHBY jumps, then RHHVF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RHHBY
1D Price
Change %
RHHBY100%
+0.46%
RHHVF - RHHBY
65%
Loosely correlated
+1.99%
NVS - RHHBY
37%
Loosely correlated
+0.74%
JNJ - RHHBY
37%
Loosely correlated
+1.56%
RHHBF - RHHBY
32%
Poorly correlated
-4.92%
BMY - RHHBY
28%
Poorly correlated
+0.60%
More